Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-25
DOI
10.1186/s12951-021-00805-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
- (2021) Wanxiao Sun et al. JOURNAL OF CONTROLLED RELEASE
- In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy
- (2021) Haimei Zhou et al. BIOMATERIALS
- Cell-Membrane-Based Biomimetic Systems with Bioorthogonal Functionalities
- (2020) Li-Li Huang et al. ACCOUNTS OF CHEMICAL RESEARCH
- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials
- (2020) Jackson G. Egen et al. IMMUNITY
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
- (2020) Xueliang Zuo et al. Journal of Hematology & Oncology
- Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy
- (2020) Haijie Han et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal
- (2020) Elana Ben-Akiva et al. Science Advances
- Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer
- (2020) Nicola Gaynor et al. SEMINARS IN CANCER BIOLOGY
- Irradiation pretreatment enhances the therapeutic efficacy of platelet-membrane-camouflaged antitumor nanoparticles
- (2020) Yin Chen et al. JOURNAL OF NANOBIOTECHNOLOGY
- Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy
- (2020) Chunai Gong et al. JOURNAL OF NANOBIOTECHNOLOGY
- Treatment after progression in the era of immunotherapy
- (2020) Salem Billan et al. LANCET ONCOLOGY
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells
- (2019) Leila Faramarzi et al. Artificial Cells Nanomedicine and Biotechnology
- Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
- (2019) Jiangsheng Xu et al. Nature Nanotechnology
- Immunotherapy and targeted therapy combinations in metastatic breast cancer
- (2019) Francisco J Esteva et al. LANCET ONCOLOGY
- Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
- (2019) Han Yao et al. Nature Biomedical Engineering
- Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells
- (2019) Xiteng Yin et al. CELLULAR ONCOLOGY
- Encapsulation of Plasmid DNA by Nanoscale Metal–Organic Frameworks for Efficient Gene Transportation and Expression
- (2019) Yantao Li et al. ADVANCED MATERIALS
- Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors
- (2019) Min Qiu et al. Advanced Healthcare Materials
- Dual-Blockade Immune Checkpoint for Breast Cancer Treatment Based on a Tumor-Penetrating Peptide Assembling Nanoparticle
- (2019) Guorui Li et al. ACS Applied Materials & Interfaces
- Integration of immunogenic activation and immunosuppressive reversion using mitochondrial-respiration-inhibited platelet-mimicking nanoparticles
- (2019) Xiaoli Mai et al. BIOMATERIALS
- Defeating relapsed and refractory malignancies through a nano-enabled mitochondria-mediated respiratory inhibition and damage pathway
- (2019) Zhengyang Yang et al. BIOMATERIALS
- The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy
- (2019) Huimin Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest
- (2019) Xiaojia Zhou et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- PD-L1 status in breast cancer: Current view and perspectives
- (2019) Semir Vranic et al. SEMINARS IN CANCER BIOLOGY
- Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
- (2019) Reham Ajina et al. SEMINARS IN CANCER BIOLOGY
- Molecular Characterization of Hypoxic Alveolar Epithelial Cells After Lung Contusion Indicates an Important Role for HIF-1α
- (2018) Matthew A. Sherman et al. ANNALS OF SURGERY
- Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug delivery
- (2018) Jing-Min Liu et al. BIOMATERIALS
- Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
- (2018) Ji-Chang Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
- (2018) Ruixiang Li et al. Acta Pharmaceutica Sinica B
- Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy
- (2018) Huaqin Zuo et al. Acta Biomaterialia
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site
- (2018) Venkatesh Teja Banala et al. Advanced Healthcare Materials
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity
- (2018) Huanbin Wang et al. Nature Chemical Biology
- Worm-Like Biomimetic Nanoerythrocyte Carrying siRNA for Melanoma Gene Therapy
- (2018) Yanming Wang et al. Small
- Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity
- (2018) Kathleen M. Kokolus et al. OncoImmunology
- Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma
- (2018) Saby George et al. JAMA Oncology
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- The generation of compartmentalized nanoparticles containing siRNA and cisplatin using a multi-needle electrohydrodynamic strategy
- (2017) Maria F. Pina et al. Nanoscale
- Hypoxic tumor microenvironment: Opportunities to develop targeted therapies
- (2016) Akhil Patel et al. BIOTECHNOLOGY ADVANCES
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer
- (2016) Yang Xiong et al. JOURNAL OF CONTROLLED RELEASE
- Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo
- (2016) Annika Frede et al. JOURNAL OF CONTROLLED RELEASE
- Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy
- (2016) Xuejiao Song et al. Nano Research
- PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
- (2016) Yi Zhao et al. Nature Communications
- Biomaterials in siRNA Delivery: A Comprehensive Review
- (2016) William Ho et al. Advanced Healthcare Materials
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Tbx5 Is Required for Avian and Mammalian Epicardial Formation and Coronary Vasculogenesis
- (2014) Nata Y.S.-G. Diman et al. CIRCULATION RESEARCH
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- A review of nanocarriers for the delivery of small interfering RNA
- (2012) Prashant Kesharwani et al. BIOMATERIALS
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
- (2010) Simon A. Hawley et al. Cell Metabolism
- Metal Carbonation of Forsterite in Supercritical CO2 and H2O Using Solid State 29Si, 13C NMR Spectroscopy
- (2010) Ja Hun Kwak et al. Journal of Physical Chemistry C
- AMP-activated protein kinase and human cancer: cancer metabolism revisited
- (2008) F P Kuhajda INTERNATIONAL JOURNAL OF OBESITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now